Daito Chemix Corporation
4366・Standard Market・Chemicals
Chemical Products Business
The core segment of Daito Chemix, manufacturing and selling Electronic Materials, Imaging Materials, and other products
| Period | Current | Previous | Change |
|---|---|---|---|
| Segment sales | ¥17,742 million | ¥17,052 million | ↑ |
| Segment profit (operating income basis) | ¥605 million | ¥577 million | ↑ |
| Segment assets | ¥26,836 million | ¥22,629 million | ↑ |
| Depreciation and amortization | ¥1,238 million | ¥1,382 million | ↓ |
| Increase in tangible and intangible fixed assets | ¥1,708 million | ¥603 million | ↑ |
| Investment in equity-method affiliates | ¥758 million | ¥0 million | ↑ |
Business Details
Manufactures and sells Electronic Materials (photosensitive materials for semiconductors and display materials), Imaging Materials (film, photographic, and printing materials), Pharmaceutical Intermediates, and Other Chemical Products. This core business accounts for approximately 91% of consolidated group sales. Major customers include FUJIFILM (¥4,220 million), Miki Sangyo (¥4,142 million), Sumitomo Chemical (¥4,104 million), and Tokyo Ohka Kogyo (¥1,722 million). Equity-method affiliate DAITO-KISCO Corporation (South Korea) handles the manufacture of photosensitive materials.
Recent Overview
Driven by Electronic Materials and Imaging Materials, sales rose 4.0%, while Pharmaceutical Intermediates plunged 76.6%
Sales in the Chemical Products Business for FY2026 (ending March 2026) were ¥17,742 million (up 4.0% year on year). Electronic Materials performed well, rising 6.9% to ¥12,042 million on expanding demand for photosensitive materials for semiconductors, while Imaging Materials also performed strongly, rising 12.2% to ¥5,092 million on the start of newly contracted products and strong instant photography demand. On the other hand, Pharmaceutical Intermediates plunged 76.6% to ¥203 million due to the impact of inventory adjustments. Segment profit improved to ¥605 million (from ¥577 million in the prior period). The company recorded an investment of ¥758 million in equity-method affiliate DAITO-KISCO Corporation, advancing the strengthening of its production system for photosensitive materials.
Key Products
Growth Drivers
- Increased sales of Electronic Materials driven by expanding demand for photosensitive materials for semiconductors (applications in high-speed communications, data centers, AI, and automotive use)
- Increased sales of Imaging Materials (up 12.2% year on year) due to strong demand for instant photography materials and the start of newly contracted products
- Expanded sales to major customers (¥4,220 million to FUJIFILM, ¥4,104 million to Sumitomo Chemical, ¥4,142 million to Miki Sangyo)
- Strengthened production capacity for photosensitive materials through equity-method investment (¥758 million) in DAITO-KISCO Corporation
- Expected bottoming-out of display materials on recovering demand for OLED-related materials
- Strategy under the medium-term management plan to expand contracted production of advanced photoresist materials and OLED materials
Risks
- Risk of inventory adjustments in Pharmaceutical Intermediates (sales plunged 76.6% year on year to ¥203 million in FY2026 (ending March 2026))
- Continued decline in sales volume and sales value of display materials
- Financial risk at equity-method affiliate DAITO-KISCO Corporation (has previously experienced negative net worth and carries a heavy debt burden)
- Impact on raw material procurement costs from geopolitical risks (the Russia-Ukraine situation, Middle East tensions, and US trade policy)
- Continuing contraction of printing materials due to the shift to paperless media
- Increased future depreciation burden associated with the substantial increase in fixed asset investment (¥1,708 million)
Last updated: June 24, 2026